Patents by Inventor Mark Cornell

Mark Cornell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency
    Patent number: 10201595
    Abstract: Compositions and methods for the treatment and/or prevention of disorders associated with C1 esterase inhibitor deficiency are disclosed.
    Type: Grant
    Filed: December 11, 2017
    Date of Patent: February 12, 2019
    Assignee: Shire ViroPharma Incorporated
    Inventors: Stephen Ruddy, Mark Cornell Manning, Ryan Erik Holcomb
  • Antibody formulations and uses thereof
    Patent number: 10195281
    Abstract: The present application relates to formulations of anti-CD105 antibodies, antigen-binding fragments thereof, and uses thereof. Another aspect relates to pre-filled syringes of the formulations of anti-CD105 antibodies or antigen-binding fragments thereof. Another aspect relates to the use of the formulations to reduce one or more signs or symptoms of an angiogenesis-related disorder such as cancers and ophthalmologic diseases.
    Type: Grant
    Filed: September 5, 2013
    Date of Patent: February 5, 2019
    Assignee: Tracon Pharmaceuticals, Inc.
    Inventors: Suzanne Benedict, Mark Cornell Manning, Brian M. Murphy, Sharon Real, Charles Theuer
  • STABLE ANTI-OSMR ANTIBODY FORMULATION
    Publication number: 20180333489
    Abstract: The present invention provides, among other things, stable formulations comprising an anti-oncostatin M receptor (OSMR) antibody and having a pH ranging from approximately 6.0-7.6, wherein less than approximately 5% of the anti-OSMR antibody exists as high molecular weight (HMW) species in the formulation.
    Type: Application
    Filed: April 11, 2018
    Publication date: November 22, 2018
    Inventors: Mark Cornell Manning, Zahra Shahrokh, Dave Nichols, Phillip M. Levesque, Ryan Erik Holcomb
  • C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency
    Patent number: 10130690
    Abstract: Compositions and methods for the treatment and/or prevention of disorders associated with C1 esterase inhibitor deficiency are disclosed.
    Type: Grant
    Filed: December 11, 2017
    Date of Patent: November 20, 2018
    Assignee: Shire ViroPharma Incorporated
    Inventors: Stephen Ruddy, Mark Cornell Manning, Ryan Erik Holcomb
  • Antibody Formulations and Uses Thereof
    Publication number: 20180311359
    Abstract: The present application relates to formulations of anti-CD105 antibodies, antigen-binding fragments thereof, and uses thereof. Another aspect relates to pre-filled syringes of the formulations of anti-CD105 antibodies or antigen-binding fragments thereof. Another aspect relates to the use of the formulations to reduce one or more signs or symptoms of an angiogenesis-related disorder such as cancers and ophthalmologic diseases.
    Type: Application
    Filed: July 13, 2018
    Publication date: November 1, 2018
    Inventors: Suzanne Benedict, Mark Cornell Manning, Brian M. Murphy, Sharon Real, Charles Theuer
  • C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency
    Patent number: 10105423
    Abstract: Compositions and methods for the treatment and/or prevention of disorders associated with C1 esterase inhibitor deficiency are disclosed.
    Type: Grant
    Filed: December 11, 2017
    Date of Patent: October 23, 2018
    Assignee: Shire ViroPharma Incorporated
    Inventors: Stephen Ruddy, Mark Cornell Manning, Ryan Erik Holcomb
  • C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency
    Patent number: 10080788
    Abstract: Compositions and methods for the treatment and/or prevention of disorders associated with C1 esterase inhibitor deficiency are disclosed.
    Type: Grant
    Filed: December 11, 2017
    Date of Patent: September 25, 2018
    Assignee: Shire ViroPharma Incorporated
    Inventors: Stephen Ruddy, Mark Cornell Manning, Ryan Erik Holcomb
  • C1-INH COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF DISORDERS ASSOCIATED WITH C1 ESTERASE INHIBITOR DEFICIENCY
    Publication number: 20180153972
    Abstract: Compositions and methods for the treatment and/or prevention of disorders associated with C1 esterase inhibitor deficiency are disclosed.
    Type: Application
    Filed: December 11, 2017
    Publication date: June 7, 2018
    Inventors: Stephen Ruddy, Mark Cornell Manning, Ryan Erik Holcomb
  • C1-INH COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF DISORDERS ASSOCIATED WITH C1 ESTERASE INHIBITOR DEFICIENCY
    Publication number: 20180110844
    Abstract: Compositions and methods for the treatment and/or prevention of disorders associated with C1 esterase inhibitor deficiency are disclosed.
    Type: Application
    Filed: December 11, 2017
    Publication date: April 26, 2018
    Inventors: Stephen Ruddy, Mark Cornell Manning, Ryan Erik Holcomb
  • C1-INH COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF DISORDERS ASSOCIATED WITH C1 ESTERASE INHIBITOR DEFICIENCY
    Publication number: 20180110843
    Abstract: Compositions and methods for the treatment and/or prevention of disorders associated with C1 esterase inhibitor deficiency are disclosed.
    Type: Application
    Filed: December 11, 2017
    Publication date: April 26, 2018
    Inventors: Stephen Ruddy, Mark Cornell Manning, Ryan Erik Holcomb
  • C1-INH COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF DISORDERS ASSOCIATED WITH C1 ESTERASE INHIBITOR DEFICIENCY
    Publication number: 20180085441
    Abstract: Compositions and methods for the treatment and/or prevention of disorders associated with C1 esterase inhibitor deficiency are disclosed.
    Type: Application
    Filed: December 11, 2017
    Publication date: March 29, 2018
    Inventors: Stephen Ruddy, Mark Cornell Manning, Ryan Erik Holcomb
  • C1-INH COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF DISORDERS ASSOCIATED WITH C1 ESTERASE INHIBITOR DEFICIENCY
    Publication number: 20170224788
    Abstract: Compositions and methods for the treatment and/or prevention of disorders associated with C1 esterase inhibitor deficiency are disclosed.
    Type: Application
    Filed: January 20, 2017
    Publication date: August 10, 2017
    Inventors: Stephen Ruddy, Mark Cornell Manning, Ryan Erik Holcomb
  • C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency
    Patent number: 9616111
    Abstract: Compositions and methods for the treatment and/or prevention of disorders associated with C1 esterase inhibitor deficiency are disclosed.
    Type: Grant
    Filed: September 15, 2015
    Date of Patent: April 11, 2017
    Assignee: Shire ViroPharma Incorporated
    Inventors: Stephen Ruddy, Mark Cornell Manning, Ryan Erik Holcomb
  • C1-INH COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF DISORDERS ASSOCIATED WITH C1 ESTERASE INHIBITOR DEFICIENCY
    Publication number: 20160015795
    Abstract: Compositions and methods for the treatment and/or prevention of disorders associated with C1 esterase inhibitor deficiency are disclosed.
    Type: Application
    Filed: September 15, 2015
    Publication date: January 21, 2016
    Inventors: Cynthia Gallagher, Steven Ruddy, Mark Cornell Manning
  • Antibody Formulations and Uses Thereof
    Publication number: 20150209430
    Abstract: The present application relates to formulations of anti-CD105 antibodies, antigen-binding fragments thereof, and uses thereof. Another aspect relates to pre-filled syringes of the formulations of anti-CD105 antibodies or antigen-binding fragments thereof. Another aspect relates to the use of the formulations to reduce one or more signs or symptoms of an angiogenesis-related disorder such as cancers and ophthalmologic diseases.
    Type: Application
    Filed: September 5, 2013
    Publication date: July 30, 2015
    Applicant: Tracon Pharmaceuticals, Inc.
    Inventors: Suzanne Benedict, Mark Cornell Manning, Brian M. Murphy, Sharon Real, Charles Theuer
  • Compositions containing stabilized retinoid
    Publication number: 20030215413
    Abstract: The present invention provides compositions useful for skin and/or hair care that contain a retinoid in which the retinoid remains stable over a sustained period of time.
    Type: Application
    Filed: March 24, 2003
    Publication date: November 20, 2003
    Applicant: L'OREAL
    Inventors: Hani Fares, Sidney P. Foltis, Thomas Re, Alan Meyers, Mark Cornell, Isabelle Hansenne
  • Outer face of a vehicle wheel
    Patent number: D512361
    Type: Grant
    Filed: August 17, 2004
    Date of Patent: December 6, 2005
    Inventor: Mark Cornell
  • Bottle
    Patent number: D496866
    Type: Grant
    Filed: March 21, 2003
    Date of Patent: October 5, 2004
    Assignee: Thomas Hine & Co.
    Inventor: Mark Cornell